Patent ID: 7071163

Claim:
A composition for targeting hepatocytes comprising: a T7 ligand covalently attached to a compound, wherein, a) said T7 ligand is selected from the group consisting of: T7 p17 protein, modified T7 p17 protein, T7 p17 rod domain, T7 p17 coiled coil domain, SEQ ID NO: 1, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, and b) said compound is selected from the group consisting of: drug, component of a drug or polynucleotide complex and polynucleotide.